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A B S T R A C T
Vascular endothelial growth factor (VEGF) stimulates endothelial cells to migrate, proliferate and form new
blood vessels. However direct delivery of VEGF has not become clinically adopted as a means of stimulating
blood vessel formation and wound healing because of its relatively poor stability and its production of immature
blood vessels. A simpler way of stimulating production of VEGF in situ is explored in this study following reports
of deoxy sugars involved in inducing VEGF production. The pro-angiogenic eﬀect of L and D isomers of deoxy
sugars (ribose, fucose and rhamnose) loaded into biodegradable chitosan/collagen hydrogels was examined
using a chick chorionic allantoic membrane assay. The L-sugars were all pro-angiogenic but only the 2-deoxy-D-
ribose had strong eﬀects on angiogenesis. Furthermore, these sugars could not be metabolised by four strains of
Staphylococcus aureus, as a metabolic substrate for growth, although some of these could be metabolised by
another typical pathogen, Pseudomonas aeruginosa. The eﬀects of 2-deoxy-D-ribose in a chitosan/collagen hy-
drogel on wound healing were also assessed. This biomaterial doubled the rate of cutaneous wound healing in
rats associated with an increase in vascularisation detected by staining for CD34 positive cells.
1. Introduction
Angiogenesis is a key issue in wound healing. Of all the angiogenic
factors, the most potent one and commonly used is vascular endothelial
growth factor (VEGF) [1–4]. This growth factor can be produced by
recombinant technology and it has been examined critically in many
studies [5–7]. However, results have been generally disappointing
when it is added on its own as it is rapidly broken down or diluted and
washed away. Recent strategies have considered developing VEGF
bound to biomaterials including hydrogels, electrospun scaﬀolds or
particles [8–11].
Heparin is a natural glycosaminoglycan present in the body at high
concentrations in wounds where it acts to bind VEGF and other pro-
angiogenic factors [12,13]. The MacNeil group have developed mate-
rials where they have sought to immobilise heparin on an electrostatic
basis either to hydrogels [14] or in a layer by layer coating of elec-
trospun scaﬀolds [13,15]. In vivo heparin binds and releases VEGF and
other pro-angiogenic mitogens [16]. VEGF activates the proliferation
and migration of endothelial cells in both normal and tumour tissue and
results in rapid generation of new blood vessels [17,18]. Accordingly
VEGF’s potential has been explored in the preparation of materials
where angiogenesis is required, for example in the preparation of syn-
thetic dermis for the treatment of full thickness burns injuries [19–21]
and to stimulate wound healing in chronic non-healing wounds such as
diabetic ulcers where the microvasculature is compromised. The need
for both is discussed later in this manuscript.
Although VEGF stimulates angiogenesis it is very expensive (930$
for 50 μg from Sigma-Aldrich), and is not stable [22,23]. Also, VEGF is
not the only pro-angiogenic growth factor involved in new blood vessel
formation and, in vivo, it is normally produced as part of a coordinated
wound healing programme with a complex cascade of factors that are
produced and released in response to hypoxia.
In contrast to the normally well-regulated production of new blood
vessels, in tumours vasculogenesis is exaggerated. A recent study (Yar
et al., 2014) showed that one of the enzymes that is highly active in
producing excessive vasculature in tumours, phosphorylase kinase,
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leads to the production of 2-deoxy-D-ribose. This D-sugar in turn leads
to the production of VEGF in tumourigenesis [24].
As 2-deoxy-D-ribose supports angiogenesis under these circum-
stances, we hypothesised that the gradual release of this sugar will
promote new blood vessels formation via the production of VEGF. In
addition, this molecule is stable and inexpensive and can be introduced
into biomaterials to hopefully give sustained release over several days
to stimulate the growth of new blood vessels.
To test this hypothesis L and D-isomers of deoxy-sugars were loaded
into biodegradable chitosan (CS)/collagen freeze gelated hydrogels
which were examined for their ability to support the formation of new
blood vessels using the chick chorionic allantoic membrane (CAM)
assay. It is important, however, to avoid promoting infection by pro-
viding simple bacterial growth substrates in biomaterials and although
it is reported that many bacteria cannot metabolise 2-deoxy-D-ribose
[25], we examined whether the L and D-isomers of deoxy-sugars could
be fermented by typical soft tissue pathogens. Finally, we examined the
ability of a CS/collagen hydrogel containing 2-deoxy-D-ribose to ac-
celerate wound healing in a rat skin wound model.
2. Experimental section
2.1. Materials
L-rhamnose and NaOH were purchased from Sigma-Aldrich (USA).
CS was purchased from Mian Scientiﬁc Company, Lahore, Pakistan and
further puriﬁed in our laboratories (degree of deacetylation (DD) 84%;
Mw: 87047.26 g/mol) [26]. Collagen was purchased from Mian Sci-
entiﬁc suppliers Lahore. PVA (Mw: 72,000, degree of hydrolysis 98%),
hydrochloric acid (HCl) was purchased from Merck (Germany). Triethyl
orthoformate (98%) was purchased from Alfa Aesar (Germany). Glacial
acetic acid (CH3COOH) was purchased from AnalaR BDH Laboratory
Supplies (UK). Ethanol (99.8%) was purchased from Sigma-Aldrich
(Germany.) 2-deoxy-D-ribose, D-fucose and L-fucose were purchased
from Sigma-Aldrich China, UK and Slovakia, respectively. 2-deoxy-L-
ribose and D-rhamnose were products of Carbosynth (UK). Brain Heart
Infusion broth and Tryptone soy broth (1% w/v) were purchased from
Oxoid Ltd. Phenol red was purchased from Sigma-Aldrich UK.
2.2. Preparation of cross-linked chitosan/collagen hydrogels by freeze
gelation
CS and collagen (0.5 g each) were dissolved in acetic acid (0.5 M,
20 mL) and stirred at room temperature until completely dissolved and
a clear solution was obtained. To this, triethyl orthoformate (4% v/v,
0.8 mL) was added as a cross-linker and the solution was further stirred
overnight for better homogeneity and cross-linking of materials. The
mixture was then poured into a petri dish and frozen at −20 °C over-
night. The frozen membranes were then immersed in pre-cooled etha-
nolic sodium hydroxide (3N) and again placed at−20 °C for 24 h. After
that, the frozen membranes were washed in 50% (v/v) ethanol solution
and then with distilled water to remove the sodium hydroxide. The
membranes were ﬁnally washed twice in absolute ethanol for 15 min
and dried at room temperature to obtain porous hydrogels.
2.3. Deoxy-sugar loading of hydrogels
For sugar loading, hydrogels were soaked in a 1 mg/ml aqueous
solution for the 2 isoforms (D and L) of the 3 sugars (ribose, fucose and
rhamnose) at 37 °C until all the liquid had been absorbed by the hy-
drogels (6 groups in total). Following storage at −20 °C overnight,
hydrogels were dried in a lyophilizer (Christ, Alpha 1–2 LD plus,
Germany) at −40 °C before further characterization.
2.4. Fourier transform infrared spectroscopy analysis
The infrared (FT-IR) spectra were recorded on photo acoustic mode
at the frequency range of 4000–400 cm−1 with 256 consecutive scans
at 8 cm−1 resolution on a Thermo-Nicolet 6700 P Fourier transform
infrared spectroscopy (FTIR) Spectrometer (USA).
2.5. Scanning electron microscopy
The surface morphology of the composite matrices was examined
under scanning electron microscope (SEM), Model JEOL JSM 6480. The
samples were gold sputtered coated prior to examination at a range of
magniﬁcations.
2.6. Assessment of angiogenic properties of hydrogels using the chick
chorionic allantoic membrane assay
Fertilized chicken (Gallus domesticus) eggs were purchased from Big
Bird (Raiwind road, Lahore, Pakistan) and incubated at 37 °C from day
2 of fertilization until day 8 in a humidiﬁed egg incubator (HHD, 435,
China). At day 8, a square window (1 cm2) was cut into the shell and
removed, and a 2 cm2 piece of the hydrogel placed onto the CAM. Each
egg was implanted with one hydrogel only (L and D isoforms of 3
deoxy-sugars).
The shell window was closed with paraﬁlm (Bemis Flexible
Packaging, USA) and sealed with adhesive tape. After implantation,
eggs were placed again at 37 °C in a 40% humidiﬁed incubator until day
14. At day 14, biomaterials were retrieved and the eggs were sacriﬁced.
Angiogenesis was quantiﬁed by taking light microscope pictures just
before biomaterials were retrieved and then blindly scored by four as-
sessors using images. The number of implanted and survived eggs is
given in the caption of respective CAM assay ﬁgures.
2.7. Fermentation of sugars by bacteria
The six sugars under investigation were compared to glucose with
respect to acting as substrates for metabolism by representative
common pathogens in wound infections.
2.7.1. Bacteria
Five bacterial strains were employed in the study; four strains of
Staphylococcus aureus and one strain of Pseudomonas aeruginosa. The S.
aureus strains were S235 −a recent clinical isolate that was used in
development of a bacterial infected skin model reported from this la-
boratory previously [27]. NCTC 6571 (Oxford) −a reference strain
commonly used as a for antibiotic sensitivity testing; strain Newman
−originating from a clinical infection but which has a defect in surface
ﬁbronectin binding protein, and L–9879–another clinical isolate but
which is hydrophilic.
2.7.2. Growth and fermentation of sugars
Bacteria were grown in Brain Heart Infusion broth for 16 h at 37 °C.
Aliquots (100 mL) of Tryptone Soy broth (1% w/v) supplemented with
phenol red (0.02% w/v; Sigma-Aldrich UK) and appropriate sugars (1%
w/v ﬁnal conc.) were added to sterile 96 well plates. 5 mL of the
overnight broth cultures of each bacterial strain was then added to
wells and incubated for 16 h at 37 °C. The ability of each strain to
ferment each sugar was judged by the production of acid and change of
the phenol red pH indicator.
2.8. Full-thickness excisional rat wound model
For in vivo experiments, only the 2-deoxy-D-ribose freeze gelated
hydrogels were tested. 20 mm diameter and 1.2 mm thickness circles
were prepared. The samples were sterilized using ethanol (70%) solu-
tion, air dried and equilibrated in PBS brieﬂy before placing on the
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wound. For animal trials, male Sprague-Dawley (SD) rats weighing
140–170 g were used in the study. The animals had free access to food
and water and were kept in a dedicated animal house facility according
to procedures approved by the Institutional Animal Ethics Committee at
CEMB, Lahore, Pakistan. Animals were anesthetized with ketamine
(100 mg/kg body weight) and xylazine (10 mg/kg body weight) and
then the fur from the dorsal side was removed with a hair trimmer
(Dingling professional hair clipper, RF-608, China). The backs of the
rats were completely shaved for adhesive tape ﬁxation and dressing.
After shaving, the backs were cleaned with ethanol and then they were
transferred onto a clean sterilized table and three circular shaped
wounds were created by removing skin at three marked areas with the
help of surgical scissors (Noorani Surgical Medical Supplies, Pakistan).
Immediately followed the excision process, one of these wounds was
covered with sterilized, 2-deoxy-D-ribose−loaded (using 70% ethanol)
membrane circles and the other was covered with the same material
membranes but without any 2-deoxy-D-ribose. Both implanted mem-
branes were sutured in position using sterile braided silk sutures
(Mersilk, diameter 220 μm). The hydrogels were covered with adhesive
plaster (Mepore, Sweden), further dressed with cotton gauze and ﬁnally
secured with white surgical adhesive tape (Nitto, Japan) to prevent
damage from self-grooming. Surgical dressings were removed three
days after membrane implantation.
A negative control group was included. For this the wound was kept
open and covered with dressing only (Mepore, Sweden) which was left
to heal naturally (sham operated control). Control hydrogel (without
sugar) and hydrogel loaded with D-deoxy-ribose were implanted. For
each group, three rats were used and on days 0, 3, 9, 11, 14 and 17 post-
wounding, the wounds were photographed. The average diameter of
the wound was determined using Image J from four independent cal-
culations for each sample. By the end of experiments, on day 17, rats
were euthanized with an overdose of anaesthesia and tissue sections
from implantation sites of normal, sham, control (hydrogels without 2-
deoxy-D-ribose) and 2-deoxy-D-ribose loaded hydrogels treated groups
were removed. The samples were ﬁxed in 3.7% paraformaldehyde
(Sigma-Aldrich, USA) solution for 24 h at room temperature. They were
dehydrated using various concentrations of ethanol and water from
70% to 100% and paraﬃn blocks were made.
2.8.1. Histology
Sections of 6 μm thick were cut from the paraﬃn embedded samples
with a microtome (Leica TP 1020 Automatic Tissue Processor) and
placed on Superfrost® plus slides (Menzel-Gläser, Denmark).
Conventional Haematoxylin and Eosin (H & E) staining and Gouldner’s
trichrome staining was performed, as previously described [28], before
mounting in DPX mounting medium (Fisher Scientiﬁc) with a coverslip.
For immunohistochemistry (IHC), 6 μm sections were processed
with a mouse/rabbit speciﬁc HRP/DAB (ABC) Detection IHC Kit
(Abcam). After rehydration, antigen retrieval and protein blocking
steps, the sections were incubated with 3 diﬀerent monoclonal anti-
bodies (rabbit anti-CD34 (Abcam) 1:1000, mouse anti-CD80 (Santa
Cruz) 1:100 and mouse anti-CD163 (AbD Serotec) 1:300) for 2 h diluted
in 1% BSA (Sigma-Aldrich). This was followed by 10 min incubation
with a secondary biotinylated goat anti-polyvalent antibody (Abcam
Detection IHC Kit). After incubation with an avidin and biotinylated
horseradish peroxidase, the target proteins were visualized by incuba-
tion in peroxidase substrate and DAB chromogen (Abcam Detection IHC
Kit). Samples were then counterstained with haematoxylin, dehydrated,
and mounted as per H & E protocol. Controls consisted of samples in-
cubated without primary and secondary antibodies, or incubated only
with secondary antibodies. Semi-quantitative assessment of the extent
of immunostaining was performed on a blinded observer basis using a
qualitative grading scale; absent = 0, mild presence = 1, large pre-
sence = 2, abundance = 3, great abundance = 4. Five representative
images from each sample at each time point were assessed by two
blinded researchers (n = 10). Example photographs depicting 0, 1, 2, 3
and 4 were provided for reference and the median value from these
scores was used. The M1/M2 ratio was also calculated for each using
the values from the blind scoring of the immunostaining.
2.9. Statistics
Diﬀerences between groups for the immunostaining were tested
with a non-parametric Kruskal-Wallis test and multiple comparisons
Fig. 1. Photographs of chitosan (CS)/collagen hy-
drogels to show their shape, ﬂexibility, and ability to
be folded.
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between individual groups using a Dunn’s test.
3. Results
3.1. Physical appearance of the hydrogel before loading sugars
The average hydrogel thickness, before submersion in saline, was
1.11 mm and after 24 h of submersion it increased to 1.37 mm. The
values are the average of three independent experiments. It is critical to
assess the physical stability of the membranes as eventually the mate-
rials will be handed over to a surgeon for application to the skin. The
surface of the membranes was smooth and devoid of any cracks. Fig. 1
shows the physical appearance of this membrane before and after being
stretched, and its ability to be draped for surgical procedures. More-
over, these membranes could be easily cut with a blade or scissors into
the desired shape. On handling, the membranes were strong and ﬂex-
ible and could be stretched.
Fig. 2. Scanning Electron Microscope (SEM) micrographs of cross-
linked CS/Collagen hydrogel showing cross-sectional view of hydro-
gels. Micrographs revealing porous structure of the hydrogels,
Magniﬁcation 200X; (A) control (without sugars), (B) D-deoxy-ribose
loaded hydrogel, (C) L-deoxy-ribose loaded hydrogel, (D) D-deoxy-
rhamnose loaded hydrogel, (E) L-deoxy-rhamnose loaded hydrogel,
(F) D-deoxy-fucose loaded hydrogel, (G) D-deoxy-fucose loaded hy-
drogel.
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3.2. Morphological and chemical characterization of the hydrogel after
loading of sugar
3.2.1. Scanning electron microscope
To investigate how diﬀerent sugars aﬀect the structure and mor-
phology of hydrogels, which plays a critical role in cell inﬁltration and
proliferation, the microscopic structures of these sugar-loaded hydro-
gels were examined by SEM (Fig. 2). A sheet-like structure with an
average pore size of 75.07 ± 34.48 μm was observed in the case of the
control hydrogels (Fig. 2a). The average pore-size of hydrogels con-
taining D and L-deoxy-ribose was 100.04 ± 24.01 μm and
93.33 ± 23.49 μm, respectively (Fig. 2b and c). In the case of hydro-
gels containing D and L-deoxy-rhamnose (Fig. 2e), the average pore-
size was 102.45 ± 23.05 μm and 110.89 ± 20.56 μm, respectively.
Hydrogels containing D and L-fucose showed average cross-sectional
pore-sizes of 72.18 ± 16.92 μm and 87.43 ± 14.11 μm respectively.
Thus, the SEM micrographs demonstrated that all the sugar-loaded
hydrogels had similar highly porous structures.
3.2.2. Fourier transform infrared spectroscopy
FTIR spectroscopy was used to look at the interactions between the
sugar and the polymers. Fig. 3 shows that the major peak for D-ribose
seen at around 3400 cm−1. The peaks of alkyl groups, in D-sugar,
showed absorbance peaks between 2700 and 2900 cm−1.
The spectra of hydrogels contain all the characteristic peaks of CS
and collagen. The peaks near 2900 cm−1 were assigned to CeH
stretching vibrations [29]. The bands which appeared near 1400 cm−1
were due to CeH bending vibrations. The peaks at 1099 cm−1 were due
to CeOeC stretching vibrations. However, in the cross-linked hydrogel
spectrum, OeH and NeH stretches also appeared at 3400–3200 cm−1
[30] as a broad peak, but there was signiﬁcant decrease in the intensity
of this hump. This may be due to the utilization of eNH2 of CS in
forming new eC]N bond. The new peak of the imine bond appeared at
1630 cm−1 [31,32].
3.3. Assessment of pro-angiogenic responses to deoxy-sugar-loaded
biomaterials using the chorionic allantoic membrane assay
As can be seen in Fig. 4 all three of the L isomers stimulated an-
giogenesis (Fig. 4C, E and G) compared to the control (without sugars).
However, for the D isomers, only the D isomer of deoxy-ribose was
strongly angiogenic (Fig. 4B). There was no signiﬁcant response to the
D isomer of deoxy-fucose and only a marginal response to the D isomer
of deoxy-rhamnose.
3.4. Ability of bacteria to metabolise l and d deoxy-sugars
While all four S. aureus strains could use glucose for fermentation,
none of these strains were able to use L- or D-isomers of the three
deoxy-sugars tested as a substrate. P. aeruginosa was, however, able to
ferment all sugars except for the L isomers of deoxy-fucose and deoxy-
rhamnose (Table 1).
3.5. Assessment of wound healing responses to deoxy-D-ribose loaded freeze
gelated hydrogel using a rat cutaneous wound model
Wound healing in rats was accelerated by the application of 2-
deoxy-D-ribose-loaded freeze gelated hydrogels. Representative macro-
scopic pictures of wounds are shown in Fig. 5. Groups including sham
operated, control hydrogels (without sugars) and 2-deoxy-D-ribose-
loaded hydrogels are shown at days 3, 9, 11, 14 and 17 post-wounding.
In conducting the animal experiments the initial hydrogel was quite
Fig. 3. FTIR spectrum of (a) D-deoxy-ribose;
FTIR of CS/Collagen hydrogels (a) D-deoxy-
fucose loaded hydrogel, (b) L-deoxy-fucose
loaded hydrogel (c) L-deoxy-rhamnose
loaded hydrogel, (d) D-deoxy-rhamnose
loaded hydrogel, (e) L-deoxy-ribose loaded
hydrogel, (f) D-deoxy-ribose loaded hy-
drogel, (g) control (without sugars).
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Fig. 4. Proangiogenic potential of CS/Collagen hydrogels using the
CAM assay. [A] The hydrogels were placed onto the CAM at day 8 of
fertilization. The ﬁgure shows light microscope images of hydrogels
on CAM at day 14 of fertilization (a) control (without sugars), (b) D-
deoxy-ribose loaded hydrogel, (c) L-deoxy-ribose loaded hydrogel, (d)
D-deoxy-rhamnose loaded hydrogel, (e) L-deoxy-rhamnose loaded
hydrogel, (f) D-deoxy-fucose loaded hydrogel, (g) L-deoxy-fucose
loaded hydrogel. The ﬁgure also shows respective explanted hydrogels
in the lower left corner of each picture. For each experiment 10 eggs
were implanted with the respective hydrogels out of which 7 chicks
survived. [B] The lower part of the picture shows statistical analysis of
the number of blood vessel for each hydrogel. (a) control (without
sugars), (b) D-deoxy-ribose loaded hydrogel, (c) L-deoxy-ribose
loaded hydrogel, (d) D-deoxy-rhamnose loaded hydrogel, (e) L-deoxy-
rhamnose loaded hydrogel, (f) D-deoxy-fucose loaded hydrogel, (g) D-
deoxy-fucose loaded hydrogel. Statistical p values are given above the
graphical bars. The values shown are means ± S.D of seven chicks
for each hydrogel.
Table 1
The ability of bacteria to ferment sugars.
Bacteria Deoxy-L-ribose Deoxy-D-ribose Deoxy-L-fucose Deoxy-D-fucose Deoxy-L-rhamnose Deoxy-D-rhamnose Glucose
S. aureus
S235a − − − − − − +
NCTC 6571b (Oxford) − − − − − − +
Newmanc − − − − − − +
L−9879d − − − − − − +
P. aeruginosa + + − + − + +
a Clinical strain used previously in infection model.
b A reference strain used for antibiotic sensitivity testing.
c Originating from a clinical strain with a defect in surface ﬁbronectin binding protein.
d A hydrophilic strain.
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robust to handle and indeed could be sutured in place. At day 3, 2-
deoxy-D-ribose-loaded hydrogels were very much attached to the sur-
rounding tissues as compared to the other tested materials with an
evident ingrowth of cells (Fig. 5), and when stretched manually showed
good mechanical strength of the wounds. At day 9, control and D-
deoxy-ribose loaded hydrogels were still intact. However, the hydrogels
were gradually absorbed and by day 11 more than 50% of the wound
area was healed with the deoxy-D-ribose hydrogel (Fig. 6). For those
treated with deoxy-D-ribose, by day 11 there was a further decrease in
the wound area, by day 14 there was no sign of deoxy-D-sugar hydrogel
remaining on the wound, and by day 17 the wound was completely
healed in contrast to control wounds and those treated with hydrogels
alone (Fig. 5). This hydrogel appeared to be totally absorbed by the
animal and could not be felt inside the healed skin when palpating. The
control hydrogel maintained its integrity until the end of the animal
study. The remnant control hydrogel was present on the wound till day
17.
Statistical analysis showed that unloaded hydrogels signiﬁcantly
accelerated wound healing and the addition of D-deoxy-ribose greatly
accelerated wound healing as can be seen by days 9, 11, 14 and 17
(p < 0.0001) (Fig. 6).
3.6. Histological and immunohistochemistry analysis of excised wound
tissues
Samples from all groups were harvested on day 17, and were
compared to normal skin from a non-treated rat.
At 17 days wound healing in the group treated with 2-deoxy-D-
Fig. 5. Representative macroscopic pictures of wounds (sham), con-
trol hydrogels (cross-linked CS/collagen hydrogel) and D-ribose
loaded hydrogels are shown at days 3, 9, 11, 14 and 17 post-
wounding.
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ribose was essentially complete and the structure of the explanted tissue
was similar to normal skin as demonstrated by H& E staining (Fig. 7).
Gouldern’s Trichrome stains in blue/green collagen while muscle, epi-
thelium, hair follicles and blood vessels are stained in red. Apart from
the muscle layer stained under the skin as shown for the normal group,
the rest looks very similar to the deoxy-D-ribose treated group with an
epithelium and hair follicles already formed. In contrast, sham and
control groups still showed disorganized granulation wound tissue by
17 days (Fig. 7).
Three diﬀerent antigens were used for the IHC (CD34 for progenitor
endothelial cells, CD80 for M1 macrophages and CD163 for M2 mac-
rophages). CD34 staining demonstrated extensive new blood vessels
through the whole thickness of the healed area for the deoxy-D-ribose
group. Blind scoring of CD34 staining for this group showed it to be
signiﬁcantly higher than for the control and sham groups also and even
higher than in the normal non-wounded group (Fig. 7).
Macrophages expressing M1 response markers are associated with
implant rejection and activation of a chronic inﬂammatory response,
while the M2 response markers are expressed by macrophages with an
inﬂammatory response associated with constructive remodelling [33].
As expected, there was no staining for M1 or M2 macrophages for the
normal unwounded group (Fig. 7). Some M1 and M2 macrophages were
seen in the other groups as would be expected post wounding or post
implantation of materials into animals. The table shown in Fig. 7 shows
an assessment of the extent of macrophage presence undertaken by
blind scoring by research staﬀ in the laboratory. The ratio of M2 to M1
presence was around 1 for wounded animals and those treated with the
unloaded CS. For those groups treated with CS loaded with 2-deoxy-D-
ribose it was slightly (non-signiﬁcantly) greater (Fig. 7).
4. Discussion
It is generally believed that biomaterials which help in the rapid
growth and inﬁltration of blood vessels show better biocompatibility
than those which exhibit delayed angiogenesis and continued in-
ﬂammation [34]. Consequently, this is a very desirable property for
tissue engineering materials to ensure survival of the tissues.
The aim of this study was to test the hypothesis that the gradual
release of 2-deoxy-D-ribose from biomaterials will promote the pro-
duction of new blood vessels and hence be of value in wound healing.
As previously stated, VEGF is known to be a key mitogen in the in-
duction of new blood vessels but delivered on its own it has proven to
be disappointing. Arguably a more productive approach would be to
initiate its induction in vivo using a biological system that leads to its
up-regulation. Looking into literature the current picture concerning
the angiogenic activity of the deoxy-sugars is far from clear. Merchan
et al. in 2010 reported anti-angiogenic activity of 2-deoxy-D-glucose.
They found that this sugar inhibited the angiogenic potential of en-
dothelial cells [35]. In contrast, a paper reported by one of the authors
in 2014 [24] that activation of phosphorylase kinase lead to the pro-
duction of a D-sugar (2-deoxy-D-ribose). This D-sugar in turn led to the
production of VEGF in tumourigenesis [24]. Our thinking was to in-
troduce this D-sugar to a biomaterial to see if it could promote angio-
genesis. Accordingly, this deoxy-D-sugar was loaded into biodegradable
hydrogels of CS/collagen.
The main ﬁndings of the study were that this sugar could be readily
incorporated into biomaterials and we conﬁrmed that it was indeed
proangiogenic using the CAM assay. Also using this assay, we explored
to what extent the angiogenic properties of the D isomer of deoxy-ri-
bose were shared with other deoxy-sugars. Here we found that all three
L isomers of deoxy-sugars (ribose, fucose and rhamnose) were proan-
giogenic but only the D isomer of deoxy-ribose was signiﬁcantly an-
giogenic.
Looking at the ability of these sugars, to act as metabolic substrates
for bacteria, we looked at four strains of S. aureus but none of them
were able to metabolise these sugars. This is encouraging news in
seeking to develop biomaterials containing these sugars as they are not
a direct source of nutrients for bacteria. Unfortunately, the Gram ne-
gative species, Pseudomonas aeruginosa, was able to metabolise all
deoxy-sugars except for the L isomers of deoxy-fucose and rhamnose.
The reason for investigating the ability of these sugars to act as sub-
strates for bacteria is that if one is preparing a biomaterial to be used on
burn wounds or chronic wounds then it would be preferable to use
materials that could not be metabolised easily by bacteria.
The next step was to assess the contribution of the D isomer of
deoxy-ribose to wound healing in vivo. For this we used a rat cutaneous
Fig. 6. Wound areas at 0, 3, 9, 11, 14 and 17 days are shown in the histograms. Negative control (open wound left to heal naturally); Control (CS/Collagen hydrogel without sugar); and
D-R (CS/Collagen hydrogel loaded with 2-deoxy-D-ribose). Results shown as mean ± SD, n = 3.
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Fig. 7. From top to bottom; H & E, Goldren-trichrome and immunostaining images at day 17. Scale bars of 0.2 mm. Assessment of the immunostaining data using a blind scoring system.
0 = absence; 1 = mild presence; 2 = large presence; 3 = abundance; 4 = great abundance. Results shown are means ± SD, n = 10. Statistics for multiple comparisons and the M2/M1
ratio are shown too.
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wound model. The addition of deoxy-D-ribose to a CS/collagen hydrogel
greatly accelerated cutaneous wound healing associated with an in-
crease in vascularisation as detected by staining for CD34 positive cells.
It was clear from this model that the CS collagen gel itself stimulated
wound healing but this was greatly increased by the addition of the D
sugar. By day 17 the D sugar treated wounds had completely closed and
histology showed the presence of very mature hair follicles. On the
basis of this evidence we would conclude that the release of D sugar
from a CS/collagen gel stimulates angiogenesis and we propose that the
increased wound healing is a natural consequence of this.
Examination of the macrophage response to the deoxy-sugar
showed a slight preponderance of M2 macrophages over M1 macro-
phages by day 17 indicative of constructive remodelling.
We suggest these deoxy-sugar-releasing hydrogels are a promising
approach to stimulate angiogenesis in chronic non-healing wounds and
also to act as a dermal replacement material in the management of
extensive full thickness burns as will be discussed shortly.
If successful there will be several advantages to using this D-sugar to
stimulate VEGF production; it is stable and inexpensive and can be
introduced into biomaterials to give sustained release over several days
to stimulate the growth of new blood vessels. One particular application
would be for use on extensive full thickness skin loss due to burns in-
juries. Here the loss of barrier function can be life-threatening [36,37].
The ﬁrst-line treatment is always the use of autologous split-skin grafts
but in extensively burned patients there are insuﬃcient grafts available
to achieve rapid restoration of the barrier layer [38]. Despite 30 years
of research in this area there remains a need for a functional and cost-
eﬀective permanent dermal substitute to assist surgeons in managing
patients with more than 30% full thickness skin loss [36].
When burns extend to more than 30 or 40% of the total body surface
area then burns surgeons will seek to use other materials, natural and
synthetic, to provide immediate wound cover and aid in the eventual
replacement of both the dermis and the epidermis [39]. It remains
technically very diﬃcult to produce a tissue engineered material that is
equivalent to a split thickness skin graft (containing all of the epidermis
and some of the dermis) that will “take” successfully on these wound
beds [40]. The major challenge is not in the production of the materials
in the laboratory (see Boyce et al) [41] but in the tissue engineered
materials surviving engraftment on the wound bed, which requires
rapid ingrowth of new blood vessels from the underlying wound bed
[41,42]. In practice, graft survival is entirely reliant on the growth of
new blood vessels from the underlying wound bed into these tissue
engineered materials which lack any intrinsic vasculature [43,44].
In practice, full thickness burns are usually treated in two stages
(where insuﬃcient autograft is available). Materials are used to provide
a vascularised dermal substitute and then when this dermis is well
vascularised then either a thin split thickness graft is placed on top of
this (often by taking further skin grafts from the initial donor sites once
healed) or cultured cells are placed over the vascularised dermis. The
two most commonly used materials to provide a vascularised dermis are
a biomaterial, Integra, which has been developed for this purpose and
donor cadaveric skin [45–47]. Integra is composed of a substrate of
bovine collagen with shark chondroitin sulphate onto which a silicon
membrane has been bonded [36]. The burn wound is excised clinically,
Integra put in place and then left in place until it becomes vascularised
which often takes three weeks or more. At this point surgeons can re-
move the silicon barrier membrane and place on top of it a thin split
thickness skin graft. The alternative material that is used is cadaveric
skin. This can be used to provide immediate wound cover (once the
burned tissue is excised) and restore the barrier function. It then be-
comes vascularised within the space of a few weeks and the donor
epidermis can then be gently removed leaving the donor vascularised
dermis in place and the epidermal barrier is replaced with a split
thickness skin graft from the patient or with epidermal cells cultured
from the patient (as discussed in MacNeil 2007) [48]. However, these
materials are not always available to burns surgeons throughout the
world because of the lack of well-run skin banks (for donor skin) or
because the purchase of Integra is viewed as too expensive. Conse-
quently, there remains a need for new eﬀective and aﬀordable bioma-
terials to provide a well vascularised dermal substrate in the manage-
ment of major burns. The key issue is that none of the current materials
contain any intrinsic vasculature hence ingrowth of vessels depends
entirely on the blood vessels in the underlying wound bed [42,49]. We
suggest that a CS-based hydrogel releasing deoxy-D-ribose merits fur-
ther exploration as a substitute for a dermis as it will stimulate new
blood vessel ingrowth and provide a vascularised wound bed for sub-
sequent grafting with a thin skin graft or cultured autologous kerati-
nocytes to provide a permanent skin barrier layer.
While the current study demonstrates clear functional wound
healing properties of a hydrogel loaded with 2 deoxy D ribose there is
much more that needs to be understood. It's not clear from this study
why one D isomer of a sugar worked and the other 2 did not. This study
does not explain the diﬀerence between L and D isomers in their me-
chanism of action. We did not in this study look at the rate of sugar
release from the hydrogels. Also, it would have been ideal to conduct
wound healing experiments in an animal model with compromised
vascularity and wound healing such as a diabetic mouse model.
Unfortunately, we were unable to obtain any of these animal models in
Pakistan and this will be an important study for the future. Another key
question is whether the angiogenic response to the sugar-releasing
hydrogel is due to the up-regulation of VEGF – we did not seek to ex-
amine that in this study – assessing the VEGF release and blocking the
action of the VEGF to see if that negates the response to the sugar re-
leasing hydrogel will also help elucidate the mechanism of action at
least to the point of conﬁrming whether the angiogenesis is dependent
on a regulation of the VEGF or not.
Thus, now that we have conﬁrmed the potent wound healing re-
sponse to the 2-deoxy-D ribose sugar further studies are merited to
obtain information on the mechanism of action and indeed to compare
its potency to the addition of the VEGF on its own.
5. Conclusion
We conclude that as the delivery of 2-deoxy-D-ribose from a hy-
drogel stimulates angiogenesis in both the CAM assay and a rat wound
healing model this oﬀers an important new approach to developing pro-
angiogenic wound healing materials for clinical use which merits fur-
ther development.
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